Immunic Ownership | Who Owns Immunic?

Immunic Ownership Summary

Immunic is owned by 1.00% institutional investors, 0.97% insiders, and 98.02% retail investors. Vanguard group is the largest institutional shareholder, holding 2.59% of IMUX shares. abrdn Healthcare Investors is the top mutual fund, with 3.48% of its assets in Immunic shares.

IMUX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunic	1.00%	0.97%	98.02%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	5.02M	2.59%	$2.68M
Gratus capital	2.11M	2.17%	$2.34M
Blackrock	679.34K	0.70%	$754.07K
Abrdn	8.24M	0.53%	$9.15M
Bvf inc/il	7.65M	0.49%	$8.49M
Soleus capital management	4.50M	0.29%	$5.00M
Laurion capital management lp	3.88M	0.25%	$4.31M
Millennium management	3.78M	0.24%	$4.20M
Morgan stanley	3.29M	0.21%	$3.65M
Nantahala capital management	2.51M	0.16%	$2.78M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Propel bio management	2.34M	1.65%	$2.62M
Avidity partners management lp	669.94K	1.46%	$6.44M
Bvf inc/il	7.65M	0.27%	$8.49M
Soleus capital management	4.50M	0.20%	$5.00M
Laurion capital management lp	3.88M	0.19%	$4.31M
683 capital management	2.45M	0.14%	$2.72M
Nantahala capital management	2.51M	0.10%	$2.78M
Gratus capital	2.11M	0.09%	$2.34M
Ikarian capital	674.66K	0.06%	$748.88K
Scientech research	26.64K	0.02%	$29.57K

Top Buyers

Holder	Shares	% Assets	Change
Soleus capital management	4.50M	0.20%	4.50M
683 capital management	2.45M	0.14%	2.45M
Propel bio management	2.34M	1.65%	2.34M
Morgan stanley	3.29M	0.00%	1.20M
Woodline partners lp	967.15K	0.00%	967.15K

Top Sellers

Holder	Shares	% Assets	Change
Avidity partners management lp	669.94K	1.46%	-4.03M
Janus henderson group	-	-	-2.69M
Colony group	-	-	-2.62M
Nantahala capital management	2.51M	0.10%	-1.87M
Omega fund management	-	-	-1.79M

New Positions

Holder	Shares	% Assets	Change	Value
683 capital management	2.45M	0.14%	2.45M	$2.72M
Propel bio management	2.34M	1.65%	2.34M	$2.62M
Woodline partners lp	967.15K	0.00%	967.15K	$1.07M
Vanguard fiduciary trust	740.54K	0.00%	740.54K	$822.00K
Hrt financial lp	493.39K	0.00%	493.39K	$547.00K

Sold Out

Holder	Change
Parallel advisors	-2.00
Caldwell sutter capital	-3.00
Capital performance advisors llp	-21.00
National bank of canada /fi/	-250.00
Allworth financial lp	-842.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	23	-63.49%	15,634,987	-69.51%	1	0.14%	14	-44.00%	2	-77.78%
Dec 31, 2025	14	-78.46%	14,479,414	-66.08%	7	0.72%	5	-81.48%	-	-100.00%
Sep 30, 2025	15	-72.22%	13,009,940	-72.05%	9	0.79%	4	-80.95%	2	-84.62%
Jun 30, 2025	55	-20.29%	50,153,922	23.98%	37	2.38%	22	-12.00%	13	-27.78%
Mar 31, 2025	9	-87.14%	17,468,208	-65.80%	19	0.76%	2	-93.33%	3	-82.35%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
abrdn Healthcare Investors	473.88K	3.48%	-4.26M
Vanguard US Total Market Shares ETF	2.63M	2.92%	-
Vanguard Total Stock Mkt Idx Inv	366.39K	2.69%	-3.30M
abrdn Life Sciences Investors	302.89K	2.22%	-2.73M
Vanguard Institutional Extnd Mkt Idx Tr	136.18K	1.00%	-1.23M
Fidelity Extended Market Index	681.80K	0.50%	38.25K
abrdn World Healthcare	47.63K	0.35%	-428.63K
Simplify Propel Opportunities ETF	43.89K	0.32%	-
BlackRock Extended Equity Market K	232.59K	0.26%	-99.00
iShares Micro-Cap ETF	301.36K	0.23%	-2.00K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 13, 2025	Nash Duane	Executive Chairman	Buy	$16.69K
Jun 05, 2025	Tardio Jason	President and COO	Buy	$9.88K
Jun 04, 2025	Vitt Daniel	CEO and Director	Buy	$11.55K
Jun 04, 2025	Neermann Joerg	-	Buy	$53.90K
Jun 05, 2025	Neermann Joerg	-	Buy	$22.80K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q3	-	-
2025 Q2	7	-
2024 Q4	1	-

IMUX Ownership FAQ

Who Owns Immunic?

Immunic shareholders are primarily institutional investors at 1.00%, followed by 0.97% insiders and 98.03% retail investors. The average institutional ownership in Immunic's industry, Biotech Stocks , is 35.75%, which Immunic falls below.

Who owns the most shares of Immunic?

Immunic’s largest shareholders are Vanguard group (5.02M shares, 2.59%), Gratus capital (2.11M shares, 2.17%), and Blackrock (679.34K shares, 0.70%). Together, they hold 5.46% of Immunic’s total shares outstanding.

Does Blackrock own Immunic?

Yes, BlackRock owns 0.70% of Immunic, totaling 679.34K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 754.07K$. In the last quarter, BlackRock increased its holdings by 18.09K shares, a 2.74% change.

Who is Immunic’s biggest shareholder by percentage of total assets invested?

Propel bio management is Immunic’s biggest shareholder by percentage of total assets invested, with 1.65% of its assets in 2.34M Immunic shares, valued at 2.62M$.

Who is the top mutual fund holder of Immunic shares?

abrdn Healthcare Investors is the top mutual fund holder of Immunic shares, with 3.48% of its total shares outstanding invested in 473.88K Immunic shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools